Characterization of the small molecule kinase inhibitor SU11248 
(Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer 
therapy with kinase inhibitors

Bairlein, Michaela

Local TagsRelease HistoryDetailsSummary

Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors

Bairlein, M. (2010). Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors. PhD Thesis, Technische Universität, München.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0010-57FC-7 Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0010-57FD-5

Genre: Thesis

Files

show Files

Locators

show

Creators

show

hide

Creators:
Bairlein, Michaela¹, Author

Affiliations:
1Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565172

Content

show

Details

show

hide

Language(s): eng - English

Dates: Accepted: 2010

Publication Status: Accepted / In Press

Pages: -

Publishing info: München : Technische Universität

Table of Contents: -

Rev. Type: -

Identifiers: eDoc: 530169

Degree: PhD

Event

show

Legal Case

show

Project information

show

Source

show